Quantitative assessment – disease impact*.

*Scenarios are denoted as DALY{age weighting constant, discount rate}.**Credibility Interval.***Incident symptomatic cases are the sum of all clinical manifestations across all incident cases.aThe clinical manifestations incorporated in the neurocysticercosis DALY estimates were epilepsy and death; note that the number of incident neurocysticercosis cases was not calculated, as the estimation started from the incidence of epilepsy (see Supporting Information S3).bThe clinical manifestations incorporated in the congenital toxoplasmosis DALY estimates were chorioretinitis at birth, chorioretinitis later in life, hydrocephalus, intracranial calcifications, central nervous system abnormalities, fetal death and neonatal death.cThe clinical manifestations incorporated in the cystic echinococcosis DALY estimates were post-surgical recovery (with rehabilitation and possible worrying), substantial post-surgical conditions, post-surgical recurrent disease, post-surgical death, and an average health state for non-reported cases; no burden was attributed to healthcare seeking cases that were not treated surgically.